Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. D'Amico F, Peyrin-Biroulet L, Danese S. N Engl J Med 2022;386:1767-1768.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

D'Amico F, Peyrin-Biroulet L, Danese S. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. N Engl J Med 2022;386:1767-1768.
PMID: 35507492